Drug · DIN 02444089 · Veterinary
NERFASIN 20
ROUTES OF ADMINISTRATION I.V. AND S.C. FOR DOGS AND CATS. ROUTE OF ADMINISTRATION I.M. FOR DOGS, CATS, AND CATTLE
Authorized, but not sold for a year or more
Authorized, but the company reports it has not been sold in Canada for at least 12 months.
Status Dormant since December 5, 2023; first marketed June 25, 2016.
- Drug Identification Number (DIN)
- 02444089
- Company (DIN owner)
- Dechra Regulatory BvBladel, --, Netherlands
- Schedule
- Prescription
- Dosage form
- Solution
- Route
- Intramuscular; Intravenous; Subcutaneous
- Class
- Veterinary
- Record last updated
- October 9, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| XYLAZINE (XYLAZINE HYDROCHLORIDE) | 20 MG | ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- June 13, 2019: NOC 22287Abbreviated New Drug Submission (ANDS) · Changes in product ownership;
- January 8, 2016: NOC 17639Supplement to an Abbreviated New Drug Submission (SANDS) · Labelling update
- August 5, 2015: NOC 17163Abbreviated New Drug Submission (ANDS)
Recalls and safety alerts that mention it
Health Canada’s recall notices do not carry licence numbers, so these are matched by name: notices whose title or product names “nerfasin”. A notice may cover another product or only some lots: read it to see what it covers.
- Nerfasin 20 injection; Presence of particlesMay 15, 2023 · Veterinary drugs · Product quality · Type I
- NERFASIN 20: Affected lot may contain the presence of particlesAugust 29, 2022 · Veterinary drugs · Product quality · Type I
- Nerfasin 20: quality issue (presence of particles)November 30, 2021 · Veterinary drugs · Product quality · Type I